These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 20545512)

  • 1. Preparation and characterization of solid dispersion of simvastatin.
    Silva TD; Arantes VT; Resende JA; Speziali NL; de Oliveira RB; Vianna-Soares CD
    Drug Dev Ind Pharm; 2010 Nov; 36(11):1348-55. PubMed ID: 20545512
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Preparation and characterization of simvastatin/hydroxypropyl-beta-cyclodextrin inclusion complex using supercritical antisolvent (SAS) process.
    Jun SW; Kim MS; Kim JS; Park HJ; Lee S; Woo JS; Hwang SJ
    Eur J Pharm Biopharm; 2007 Jun; 66(3):413-21. PubMed ID: 17240129
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Preparation, characterization, stability and in vitro-in vivo evaluation of pellet-layered Simvastatin nanosuspensions.
    Luo Y; Xu L; Tao X; Xu M; Feng J; Tang X
    Drug Dev Ind Pharm; 2013 Jul; 39(7):936-46. PubMed ID: 23046250
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Preparation, characterization and tableting of cilnidipine solid dispersions.
    Hu L; Song W; Niu F; Jiao K; Jia Z
    Pak J Pharm Sci; 2013 May; 26(3):629-36. PubMed ID: 23625441
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Development of novel itraconazole-loaded solid dispersion without crystalline change with improved bioavailability.
    Park YJ; Xuan JJ; Oh DH; Balakrishnan P; Yang HJ; Yeo WH; Lee MK; Choi HG; Yong CS
    Arch Pharm Res; 2010 Aug; 33(8):1217-25. PubMed ID: 20803125
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of drug-carrier interaction on the dissolution behavior of solid dispersion tablets.
    Srinarong P; Kouwen S; Visser MR; Hinrichs WL; Frijlink HW
    Pharm Dev Technol; 2010; 15(5):460-8. PubMed ID: 20735300
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Physicochemical and dissolution studies of simvastatin solid dispersions with Pluronic F127.
    Karolewicz B; Gajda M; Owczarek A; Pluta J; Górniak A
    Pharmazie; 2014 Aug; 69(8):589-94. PubMed ID: 25158569
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Solubility enhancement of simvastatin: a review.
    Murtaza G
    Acta Pol Pharm; 2012; 69(4):581-90. PubMed ID: 22876598
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Extruded Soluplus/SIM as an oral delivery system: characterization, interactions, in vitro and in vivo evaluations.
    Zhang Y; Liu Y; Luo Y; Yao Q; Zhong Y; Tian B; Tang X
    Drug Deliv; 2016 Jul; 23(6):1902-11. PubMed ID: 25268150
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Highly ordered mesoporous carbon nanomatrix as a new approach to improve the oral absorption of the water-insoluble drug, simvastatin.
    Zhang Y; Wang H; Gao C; Li X; Li L
    Eur J Pharm Sci; 2013 Aug; 49(5):864-72. PubMed ID: 23791638
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Preparation and characterization of simvastatin/DMβCD complex and its pharmacokinetics in rats.
    Gu F; Ning J; Fan H; Wu C; Wang Y
    Acta Pharm; 2018 Jun; 68(2):145-157. PubMed ID: 29702479
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Study of the physicochemical properties and oral bioavailability of the solid dispersion of cantharidin with polyethylene glycol 4000.
    Dang YJ; Hu CH; An LN; Zhu CY
    Methods Find Exp Clin Pharmacol; 2010 Apr; 32(3):157-62. PubMed ID: 20448857
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Spray-dried amorphous solid dispersions of simvastatin, a low tg drug: in vitro and in vivo evaluations.
    Ambike AA; Mahadik KR; Paradkar A
    Pharm Res; 2005 Jun; 22(6):990-8. PubMed ID: 15948043
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The characteristics and mechanism of simvastatin loaded lipid nanoparticles to increase oral bioavailability in rats.
    Zhang Z; Bu H; Gao Z; Huang Y; Gao F; Li Y
    Int J Pharm; 2010 Jul; 394(1-2):147-53. PubMed ID: 20435111
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Intraorally fast-dissolving particles of a poorly soluble drug: preparation and in vitro characterization.
    Laitinen R; Suihko E; Toukola K; Björkqvist M; Riikonen J; Lehto VP; Järvinen K; Ketolainen J
    Eur J Pharm Biopharm; 2009 Feb; 71(2):271-81. PubMed ID: 18824096
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Preparation and characterization of gliclazide-polyethylene glycol 4000 solid dispersions.
    Patil MP; Gaikwad NJ
    Acta Pharm; 2009 Mar; 59(1):57-65. PubMed ID: 19304558
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dispersion of daidzein with polyvinylpyrrolidone effects on dissolution rate and bioavailability.
    Feng BL; Li HW; Zhou MY; Lu W
    Zhong Yao Cai; 2011 Apr; 34(4):605-10. PubMed ID: 21809547
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Co-solvent evaporation method for enhancement of solubility and dissolution rate of poorly aqueous soluble drug simvastatin: in vitro-in vivo evaluation.
    Pandya P; Gattani S; Jain P; Khirwal L; Surana S
    AAPS PharmSciTech; 2008; 9(4):1247-52. PubMed ID: 19115110
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The influence of povidone K17 on the storage stability of solid dispersions of nimodipine and polyethylene glycol.
    Smikalla MM; Urbanetz NA
    Eur J Pharm Biopharm; 2007 Apr; 66(1):106-12. PubMed ID: 17055711
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Characterization and stability of solid dispersions based on PEG/polymer blends.
    Bley H; Fussnegger B; Bodmeier R
    Int J Pharm; 2010 May; 390(2):165-73. PubMed ID: 20132875
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.